Immunological therapy of sepsis: experimental therapies

被引：51

作者：

Arndt, P ^{[1
]}

Abraham, E ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA

来源：

INTENSIVE CARE MEDICINE | 2001年 / 27卷 / Suppl 1期

关键词：

D O I：

10.1007/s001340000574

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：S104 / S115

页数：12

共 116 条

[41] ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J].

FONG, YM ;

TRACEY, KJ ;

MOLDAWER, LL ;

HESSE, DG ;

MANOGUE, KB ;

KENNEY, JS ;

LEE, AT ;

KUO, GC ;

ALLISON, AC ;

LOWRY, SF ;

CERAMI, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1627-1633

[42] MENINGOCOCCEMIA AND PURPURA FULMINANS IN ADULTS - ACUTE DEFICIENCIES OF PROTEIN-C AND PROTEIN-S AND EARLY TREATMENT WITH ANTITHROMBIN-III CONCENTRATES [J].

FOURRIER, F ;

LESTAVEL, P ;

CHOPIN, C ;

MAREY, A ;

GOUDEMAND, J ;

RIME, A ;

MANGALABOYI, J .

INTENSIVE CARE MEDICINE, 1990, 16 (02) :121-124

[43] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].

GERARD, C ;

BRUYNS, C ;

MARCHANT, A ;

ABRAMOWICZ, D ;

VANDENABEELE, P ;

DELVAUX, A ;

FIERS, W ;

GOLDMAN, M ;

VELU, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550

[44]

GIRARDIN E, 1992, J INFECT DIS, V165, P695, DOI 10.1093/infdis/165.4.695

[45] Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis [J].

Giroir, BP ;

Quint, PA ;

Barton, P ;

Kirsch, EA ;

Kitchen, L ;

Goldstein, B ;

Nelson, BJ ;

Wedel, NI ;

Carroll, SF ;

Scannon, PJ .

LANCET, 1997, 350 (9089) :1439-1443

[46] ADMINISTRATION OF LOW-DOSE ENDOTOXIN TO HEALTHY HUMANS INCREASES C5A BINDING TO CIRCULATING NEUTROPHILS [J].

GRANOWITZ, EV ;

PORAT, R ;

GELFAND, JA ;

WOLFF, SM ;

DINARELLO, CA .

JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :480-482

[47] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].

GREENMAN, RL ;

SCHEIN, RMH ;

MARTIN, MA ;

WENZEL, RP ;

MACINTYRE, NR ;

EMMANUEL, G ;

CHMEL, H ;

KOHLER, RB ;

MCCARTHY, M ;

PLOUFFE, J ;

RUSSELL, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102

[48] An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyI-L-arginine hydrochloride (546C88), in patients with septic shock [J].

Grover, R ;

Zaccardelli, D ;

Colice, G ;

Guntupalli, K ;

Watson, D ;

Vincent, JL .

CRITICAL CARE MEDICINE, 1999, 27 (05) :913-922

[49] p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E(2) biosynthesis stimulated by interleukin-1 beta [J].

Guan, ZH ;

Baier, LD ;

Morrison, AR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :8083-8089

[50]

Harada A, 1996, MOL MED TODAY, V2, P482

← 1 2 3 4 5 6 7 8 9 10 →